hVIVO plc (LON:HVO – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 28.04 ($0.35) and traded as high as GBX 28.50 ($0.35). hVIVO shares last traded at GBX 27.20 ($0.34), with a volume of 1,771,474 shares traded.
hVIVO Trading Up 1.7 %
The firm has a market capitalization of £188.26 million, a PE ratio of -1.00 and a beta of 0.99. The stock’s 50-day moving average price is GBX 28.04 and its 200 day moving average price is GBX 24.20. The company has a debt-to-equity ratio of 9.83, a current ratio of 1.46 and a quick ratio of 1.16.
hVIVO Cuts Dividend
The business also recently announced a dividend, which will be paid on Monday, May 20th. Stockholders of record on Thursday, April 18th will be given a dividend of GBX 0.20 ($0.00) per share. This represents a dividend yield of 0.68%. The ex-dividend date is Thursday, April 18th.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Articles
- Five stocks we like better than hVIVO
- Are Penny Stocks a Good Fit for Your Portfolio?
- Silicon Motion Proves That AI in Motion Stays in Motion
- Investing in Construction Stocks
- Undervalued UnitedHealth Group Won’t Be For Long
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
